Freshfields advises SERB Pharmaceuticals on acquisition of US rights to bentracimab from SFJ Pharmaceuticals

The Sponsor

Loading page...

Freshfields advises SERB Pharmaceuticals on acquisition of US rights to bentracimab from SFJ Pharmaceuticals | The Sponsor - The Sponsor